Justice | Jotup

Bragar Eagel & Squire, P.C. Is Investigating SSR, Inari Medical, and Entravision and Encourages Investors to Contact the Firm

Retrieved on:

Wednesday, March 13, 2024

EST, Entravision Communications, SSR, News, Investigation, P.C, Justice, CID, Annual report, SSRM, EVC, Meal, Audit

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points:

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
On this news, SSR's stock price fell $5.22 per share, or 53.70%, to close at $4.50 per share on February 13, 2024.
The CID requests information and documents primarily relating to meals and consulting service payments provided to health care professionals (“HCPs”).
On this news, shares of Entravision Communications Corp. have dropped more than 50% in premarket trading on March 6, 2024.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against B. Riley Financial, Inc. (RILY)

Retrieved on:

Tuesday, March 12, 2024

FRG, Franchise Group, Crime, GPM, Defendant, News, Bloomberg, Suite, Complaint, Justice, Court, Cryptocurrency

LOS ANGELES, March 12, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming March 25, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired B. Riley Financial, Inc. (“B.

Key Points:

LOS ANGELES, March 12, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming March 25, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired B. Riley Financial, Inc. (“B.
Riley” or the “Company”) (NASDAQ: RILY ) common stock between May 10, 2023 and November 9, 2023, inclusive (the “Class Period”).
In May 2023, B. Riley entered into an agreement to assist its client, Brian Kahn, in leading a management buyout of Franchise Group, Inc. (“FRG”).
On November 2, 2023, Kahn was implicated as the unnamed coconspirator in a conspiracy to defraud investors of $294 million in funds.

PhRMA Secretly Funds Campaign to Kill Rent Control, per Justice for Renters

Retrieved on:

Thursday, April 4, 2024

This latest move is part of an ongoing shell game carried out by PhRMA and the pharmaceutical companies it represents to avoid public scrutiny, including that of the press.

Key Points:

This latest move is part of an ongoing shell game carried out by PhRMA and the pharmaceutical companies it represents to avoid public scrutiny, including that of the press.
“This is a shining example of how corporate greed puts both patients and tenants at risk,” said Susie Shannon, campaign manager for Justice for Renters .
PhRMA has a PAC called the Pharmaceutical Research and Manufacturers of America California Initiative Fund.
That PAC contributed an initial $10,000 to the California Business Roundtable PAC, which in turn contributed $250,000 to Californians to Protect Affordable Housing, a PAC opposing the Justice for Renters Act.

Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

Retrieved on:

Monday, April 1, 2024

Biotechnology, FDA, Health, Pharmaceutical, Clinical Trials, Letter, Chairperson, Executive Committee, TSX, OTCQX, Justice, Food

Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration (“FDA”) that otenaproxesul has been placed on clinical hold, postponing the initiation of the planned Phase II trial.

Key Points:

Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration (“FDA”) that otenaproxesul has been placed on clinical hold, postponing the initiation of the planned Phase II trial.
Antibe expects to receive a formal Clinical Hold Letter from the FDA within 30 days outlining their rationale and further details.
Separately, the Company announced that Nuance Pharma Limited has commenced legal action in the Ontario Superior Court of Justice to seek recognition of and enforce the arbitration award in Ontario previously announced by Antibe in its press release of March 4, 2024.
Nuance Pharma is seeking the appointment of a receiver as part of its relief; a hearing date has not been set.

Iveda Finds 84% of Americans Are Concerned About Violence in The Country; Many Believe AI Could Help

Retrieved on:

Thursday, March 28, 2024

Iveda® (NASDAQ:IVDA), the global solution for cloud-based AI, today released new data which shows that 84% of Americans are concerned about the rising rate of violence in the United States.

Key Points:

Iveda® (NASDAQ:IVDA), the global solution for cloud-based AI, today released new data which shows that 84% of Americans are concerned about the rising rate of violence in the United States.
In fact, the average American (79%) noted that they have changed their daily routine out of concern for their safety and wellbeing.
Yet, safety in schools and other public places remains an increasingly pressing issue with concerns around violence, bullying, theft, and vandalism putting individuals at risk.
“As the U.S. leans on AI to keep people safe, it’s critical to understand the average American’s sentiment on the subject.

Two From Lyons & Simmons Among Top Young Personal Injury Attorneys in Texas

Retrieved on:

Tuesday, March 26, 2024

Legal, Professional Services, Fechner, Next Generation, Lawyer, LLP, Steven Naifeh, Justice

Plaintiffs personal injury attorneys Stephen Higdon and Michael Fechner of the trial firm Lyons & Simmons LLP have again been honored among the top young attorneys in the state.

Key Points:

Plaintiffs personal injury attorneys Stephen Higdon and Michael Fechner of the trial firm Lyons & Simmons LLP have again been honored among the top young attorneys in the state.
Higdon and Fechner were recognized in the prestigious Texas Rising Stars legal guide based on their extensive experience handling a wide range of catastrophic personal injury and wrongful death cases in courts throughout the country.
He is a member of the Texas Trial Lawyers Association, Dallas Trial Lawyers Association, Dallas Association of Young Lawyers and the Association of Former Law Clerks of the Eastern District of Texas.
He is a member of the Dallas Association of Young Lawyers, Texas Trial Lawyers Association, Dallas Trial Lawyers Association and the American Association for Justice.

MyPrize Emerges Out of Stealth With $140 Million Total Enterprise Value, the Most Valuable Online Social Casino Pre-Launch

Retrieved on:

Wednesday, March 27, 2024

MyPrize transcends those boundaries, giving players and fans what they have been desperately craving: a unified, open platform that combines the best of both online gaming and streaming.

Key Points:

MyPrize transcends those boundaries, giving players and fans what they have been desperately craving: a unified, open platform that combines the best of both online gaming and streaming.
MyPrize radically transforms the way players can interact and engage with their favorite streamers, friends, and online games together.
MyPrize brings scale and institutional credibility to this emerging industry as the most valuable venture-backed online social casino pre-launch.
"With the support of our investors and our team’s commitment to rapid product innovation, MyPrize will define the future of online social gaming."

Sublime Systems Selected by U.S. Department of Energy to Receive $87M Investment to Accelerate Commercial-Scale, True-Zero Cement Manufacturing Technology

Retrieved on:

Monday, March 25, 2024

“The Department of Energy has cleared this obstacle through funding from OCED’s Industrial Demonstrations Program, embracing its unique role in supporting the deployment of the decarbonized technologies of tomorrow.

Key Points:

“The Department of Energy has cleared this obstacle through funding from OCED’s Industrial Demonstrations Program, embracing its unique role in supporting the deployment of the decarbonized technologies of tomorrow.
“The USW congratulates Sublime on being selected to receive this groundbreaking funding from the Department of Energy,” said USW International President Dave McCall.
It has since scaled its electrochemical cement manufacturing to a pilot capacity of 250 metric tons per year (TPY).
Sublime has already secured capacity reservations for more than 45,000 tons of the Sublime Cement™ that will be produced out of Holyoke.

Fair Isaac Corporation (FICO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Retrieved on:

Thursday, March 21, 2024

Class Action Lawsuit, Professional Services, Legal, Letter, Justice, FICO

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fair Isaac Corporation (“FICO” or “the Company”) (NYSE: FICO).

Key Points:

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fair Isaac Corporation (“FICO” or “the Company”) (NYSE: FICO).
Investors who purchased FICO securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FICO .
You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Nachawati Law Group Partner Earns Texas Rising Stars Honor

Retrieved on:

Thursday, March 21, 2024

Legal, Professional Services, Thomson Reuters, Research, Justice, American Association for Justice, Dallas Bar Association, Herbicide

Dallas-based Nachawati Law Group is pleased to announce that partner Erin Wood has earned a place on the 2024 edition of Texas Rising Stars, a distinguished list of the state’s top young attorneys published by Thomson Reuters, as part of its Super Lawyers process.

Key Points:

Dallas-based Nachawati Law Group is pleased to announce that partner Erin Wood has earned a place on the 2024 edition of Texas Rising Stars, a distinguished list of the state’s top young attorneys published by Thomson Reuters, as part of its Super Lawyers process.
Our entire firm is proud to have Erin in our corner.”
Texas Rising Stars honorees must be age 40 or younger or have been practicing law for just 10 years or less.
“I am very grateful to my clients and peers within the industry who helped make this recognition possible.”
The 2024 edition of Texas Rising Stars marks the seventh consecutive year to include Ms. Wood.
Ms. Wood is a member of the Dallas Women Lawyers Association, Dallas Bar Association, Texas Trial Lawyers Association, American Association for Justice and the Junior League of Dallas.